SlideShare a Scribd company logo
1 of 22
Granuloma Inguinale,
Lymphogranuloma Venereum,
Gonorrhea
082012100062
Nur Hanisah Zainoren
Objective
 To understand the underlying causes of the
diseases
 To understand the clinical findings of the
diseases
 To know and memorize the drug used for the
treatment of the diseases
Pathology of the Diseases
Granuloma Inguinale
 Chronic, relapsing granulomatous anogenital
infection
 Due to: Calymmatobacterium granulomatis
 Lesion occur on the skin or mucous membranes of
the genitalia or perineal area
 Painless infiltrated nodules that soon slough.
 A shallow, sharply demarcated ulcer forms, with a
beefy-red friable base of granulation tissue.
Lymphogranuloma Venereum
 LGV is an acute and chronic sexually transmitted
disease caused by Chlamydia trachomatis types
L1-L3
 Disease is acquired during intercourse or through
contact with contaminated exudate from active
lesions.
 After the genital lesions disappears, the infection
spreads to lymph channels and lymph nodes of
genital and rectal areas.
Gonorrhea
 Caused by: Neisseria Gonorrrhoeae
 Transmitted during sexual activity and has greater
incidence in the 15-29-year-old age group.
 Characterized by thick discharge from the penis
and vagina.
 In addition to male reproductive organs & female
genital tract, gonorrhea may infect the rectum,
throat, eyes, blood, skin & joints.
Pharmacotherapy of the
Diseases
Granuloma Inguinale
 Long duration of therapy
 The following recommended regimens should be
given for 3 weeks or until all lesions have healed:
Drug Dose Route
Azithromycin 1g
once weekly
O
Ciprofloxacin 700mg
twice daily
O
Doxycycline 100mg
twice daily
O
Erythromycin 500mg
4 times daily
O
TREATMENT OF
Lymphogranuloma Venereum
 Patient with a clinical presentation suggestive of
LGV should be treated empirically.
Drug Dose Route
Azithromycin 1g
once weekly
For 3 weeks
O
Doxycycline
*C/I in
pregnancy
100mg
twice daily
for 21 days
O
Erythromycin 500mg
4 times daily
For 21 days
O
TREATMENT OF
Gonorrhea
 The choice of which regimen to use should be based on
the national prevalences of antibiotic resistant organisms.
 Nationwide, strains of gonococci that are resistant to
penicillin, tetracycline, or ciprofloxacin have been
increasingly observed.
 Hence no longer be considered as 1st line therapy
 Treatment of:
1. Uncomplicated Gonorrhea
2. Disseminated gonococcal infection
3. Endocarditis
4. Postgonococcal urethritis and cervicitis
5. Pelvic inflammatory disease
TREATMENT OF
Gonorrhea
 1. Uncomplicated Gonorrhea
 Higher dose of IM Ceftriaxone in combination with
second drug (Azithromycin or Doxycyline)
regardless of concern for possible secondary infection
with chlamydia.
 For uncomplicated gonococcal infection of the cervix,
urethra, and rectum and pharyngeal gonorrhea
Ceftriaxone (250mg IM) + Azithromycin (1000mg orally as
SD) / Doxycycline (100mg BD for 7 days)
TREATMENT OF
*In case where an oral cephalosporin is the only option,
Cefixime (400mg, O, SD) can be combined with
Azithromycin/Doxycycline as above
but a “test of cure” is recommended 1 week after treatment
Gonorrhea
 2. Disseminated gonococcal infection should be
treated with:
1st option
 Ceftriaxone (1g daily, IV, until 48 hours after improvement
begins)
Cefixime (400mg daily, O, to complete at least one week of
antimicrobial therapy)
2nd option
 Oral fluoroquinolone :
Ciprofloxacin (500mg, BD)
OR
Levofloxacin (500mg, OD)
Switched to
for 7 days
TREATMENT OF
Gonorrhea
 3. Endocarditis should be treated with:
 Ceftriaxone ( 2g every 24 hours, IV, for at least 3 weeks)
 4. Postgonococcal urethritis and cervicitis are
treated with a regimen of erythromycin,
doxycycline or azithromycin
 5. Pelvic inflammatory disease:
1st option
 Cefoxitin (2g parenterally every 6 hours) OR
Cefotetan (2g IV every 12 hours)
 Doxycycline (100mg every 12 hours)
TREATMENT OF
Gonorrhea
 Pelvic inflammatory disease:
2nd option
 Clindamycin (900mg, IV every 8 hours)
 Gentamicin ( IV as a 2mg/kg loading dose followed by
1.5 mg/kg every 8 hours)
3rd option
 Ceftriaxone (250mg IM, SD) OR
[Cefoxitin (2g IM, SD) + Probenecid (1g orally as a
SD)]
 Doxycycline (100mg BD for 14 days)
 With or without Metronidazole (500mg, BD for 14 days)
TREATMENT OF
Conclusion
1. Granuloma inguinale
 Caused by: Calymmatobacterium granulomatis
 Treatment:
Drug Dose Route
Azithromycin 1g
once weekly
O
Ciprofloxacin 700mg
twice daily
O
Doxycycline 100mg
twice daily
O
Erythromycin 500mg
4 times daily
O
2. Lymphogranuloma Venereum:
 Caused by: Chlamydia trachomatis types L1-L3
 Treatment:
Drug Dose Route
Azithromycin 1g
once weekly
For 3 weeks
O
Doxycycline
*C/I in pregnancy
100mg
twice daily
for 21 days
O
Erythromycin 500mg
4 times daily
For 21 days
O
3. Gonorrhea
 Caused by: Neisseria Gonorrrhoeae
 Treatment:
1.Uncomplicated Gonorrhea
-Ceftriaxone/Cefixime+Azithromycin/Doxycycline
2.Disseminated gonococcal infection
-CeftriaxoneCefixime or
-Oral fluoroquinolones (Ciprofloxacin/Levofloxacin)
3.Endocarditis
-Ceftriaxone
4.Postgonococcal urethritis and cervicitis
-Erythromycin, Doxycycline or Azithromycin
5.Pelvic inflammatory disease
-Cefoxitin/Cefotetan+Doxycycline
-Clindamycin+Gentamicin
- Ceftriaxone OR [Cefoxitin + Probenecid] + Doxycycline
With or without Metronidazole
Reference
 Stephen J.McPhee, Macine A.Papakadis, Current
Medical Diagnosis and Treatment, McGrawHill.
Thank you 

More Related Content

What's hot

What's hot (20)

Scabies
ScabiesScabies
Scabies
 
Mumps
MumpsMumps
Mumps
 
Chickenpox
ChickenpoxChickenpox
Chickenpox
 
Lgv
LgvLgv
Lgv
 
Measles
MeaslesMeasles
Measles
 
Mumps presentation s agun
Mumps presentation   s agunMumps presentation   s agun
Mumps presentation s agun
 
Gonorrhoea
GonorrhoeaGonorrhoea
Gonorrhoea
 
Measles
MeaslesMeasles
Measles
 
Genital warts
Genital wartsGenital warts
Genital warts
 
Genital herpes : Symptoms, causes diagnosis and treatment
Genital herpes : Symptoms, causes diagnosis and treatmentGenital herpes : Symptoms, causes diagnosis and treatment
Genital herpes : Symptoms, causes diagnosis and treatment
 
Cystitis INFLAMMATION OF URINARY BLADDER
Cystitis INFLAMMATION OF URINARY BLADDERCystitis INFLAMMATION OF URINARY BLADDER
Cystitis INFLAMMATION OF URINARY BLADDER
 
MANUAL VACUUM ASPIRATION
MANUAL VACUUM ASPIRATIONMANUAL VACUUM ASPIRATION
MANUAL VACUUM ASPIRATION
 
Scabies
ScabiesScabies
Scabies
 
Hydrocele
HydroceleHydrocele
Hydrocele
 
Vulvovaginal candidiasis
Vulvovaginal  candidiasisVulvovaginal  candidiasis
Vulvovaginal candidiasis
 
Cervical erison
Cervical erisonCervical erison
Cervical erison
 
Vaginal discharge
Vaginal dischargeVaginal discharge
Vaginal discharge
 
Carbuncle
CarbuncleCarbuncle
Carbuncle
 
Warts
WartsWarts
Warts
 
Gonorrhea
GonorrheaGonorrhea
Gonorrhea
 

Viewers also liked

Calymmatobacterium granulomatis
Calymmatobacterium granulomatisCalymmatobacterium granulomatis
Calymmatobacterium granulomatis
Diana Restrepo
 
Dst – doenças sexualmente transmissíveis
Dst – doenças sexualmente transmissíveisDst – doenças sexualmente transmissíveis
Dst – doenças sexualmente transmissíveis
stcnsaidjv
 

Viewers also liked (20)

Granuloma inguinale
Granuloma inguinaleGranuloma inguinale
Granuloma inguinale
 
Lymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGVLymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGV
 
Granuloma inguinal
Granuloma inguinalGranuloma inguinal
Granuloma inguinal
 
Calymmatobacterium granulomatis
Calymmatobacterium granulomatisCalymmatobacterium granulomatis
Calymmatobacterium granulomatis
 
Linfogranuloma venereo y Donovanosis
Linfogranuloma venereo y DonovanosisLinfogranuloma venereo y Donovanosis
Linfogranuloma venereo y Donovanosis
 
Clinical cases from infection diseases hospital part 2
Clinical cases from infection diseases hospital part 2Clinical cases from infection diseases hospital part 2
Clinical cases from infection diseases hospital part 2
 
LGV
LGVLGV
LGV
 
Microbacterias
MicrobacteriasMicrobacterias
Microbacterias
 
Std
StdStd
Std
 
STDs - Dr. Mark Maynard
STDs - Dr. Mark MaynardSTDs - Dr. Mark Maynard
STDs - Dr. Mark Maynard
 
Gbs
GbsGbs
Gbs
 
Group B strep
Group B strepGroup B strep
Group B strep
 
Adolescent sti ucaya
Adolescent sti ucayaAdolescent sti ucaya
Adolescent sti ucaya
 
DOENÇAS SEXUALMENTE TRANSMISSÍVEIS
DOENÇAS SEXUALMENTE TRANSMISSÍVEISDOENÇAS SEXUALMENTE TRANSMISSÍVEIS
DOENÇAS SEXUALMENTE TRANSMISSÍVEIS
 
Calymmatobacterium (donovania) granulomatis
Calymmatobacterium (donovania) granulomatisCalymmatobacterium (donovania) granulomatis
Calymmatobacterium (donovania) granulomatis
 
Donovanose slide
Donovanose slideDonovanose slide
Donovanose slide
 
Lgv by aseem
Lgv by aseemLgv by aseem
Lgv by aseem
 
Ngu
NguNgu
Ngu
 
Dst – DoençA Sexualmente
Dst – DoençA SexualmenteDst – DoençA Sexualmente
Dst – DoençA Sexualmente
 
Dst – doenças sexualmente transmissíveis
Dst – doenças sexualmente transmissíveisDst – doenças sexualmente transmissíveis
Dst – doenças sexualmente transmissíveis
 

Similar to Granuloma inguinale, lymphogranuloma venereum, gonorrhea

GENITAL TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptxGENITAL TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptx
PatrickMukoso
 

Similar to Granuloma inguinale, lymphogranuloma venereum, gonorrhea (20)

Urethritis
UrethritisUrethritis
Urethritis
 
STI'S
STI'SSTI'S
STI'S
 
PID
PIDPID
PID
 
GENITAL TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptxGENITAL TRACT INFECTIONS.pptx
GENITAL TRACT INFECTIONS.pptx
 
Vaginal disgarge
Vaginal disgargeVaginal disgarge
Vaginal disgarge
 
Presentation (2).pptx
Presentation (2).pptxPresentation (2).pptx
Presentation (2).pptx
 
Unit vi
Unit viUnit vi
Unit vi
 
27 uti by mersha
27 uti by mersha27 uti by mersha
27 uti by mersha
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptx
 
Syndromic management of sexually transmitted disease
Syndromic management of sexually transmitted diseaseSyndromic management of sexually transmitted disease
Syndromic management of sexually transmitted disease
 
pharmacotherapy of Uti
pharmacotherapy of Utipharmacotherapy of Uti
pharmacotherapy of Uti
 
Gonorrhea (1)
Gonorrhea (1)Gonorrhea (1)
Gonorrhea (1)
 
Infections.pptx
Infections.pptxInfections.pptx
Infections.pptx
 
Management of acute pid
Management of acute pidManagement of acute pid
Management of acute pid
 
HIV AND OPPORTUNISTIC INFECTIONS IN HIV.pptx
HIV AND OPPORTUNISTIC INFECTIONS  IN HIV.pptxHIV AND OPPORTUNISTIC INFECTIONS  IN HIV.pptx
HIV AND OPPORTUNISTIC INFECTIONS IN HIV.pptx
 
Gonorrhoea & Syphilis
Gonorrhoea & Syphilis Gonorrhoea & Syphilis
Gonorrhoea & Syphilis
 
endometritis.pptx
endometritis.pptxendometritis.pptx
endometritis.pptx
 
10. STI.pptx
10. STI.pptx10. STI.pptx
10. STI.pptx
 
Pharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosisPharmacotherapy of tuberculosis
Pharmacotherapy of tuberculosis
 
Clindamycin
ClindamycinClindamycin
Clindamycin
 

More from hanisahwarrior

PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
hanisahwarrior
 

More from hanisahwarrior (20)

Kursus perawatan ibadah pesakit
Kursus perawatan ibadah pesakitKursus perawatan ibadah pesakit
Kursus perawatan ibadah pesakit
 
SCROTAL SWELLING
SCROTAL SWELLINGSCROTAL SWELLING
SCROTAL SWELLING
 
MOOD DISORDERS
MOOD DISORDERSMOOD DISORDERS
MOOD DISORDERS
 
Preoperative Preparations
Preoperative PreparationsPreoperative Preparations
Preoperative Preparations
 
Hypoglycemia
Hypoglycemia Hypoglycemia
Hypoglycemia
 
SHOULDER SPORT INJURIES
SHOULDER SPORT INJURIES SHOULDER SPORT INJURIES
SHOULDER SPORT INJURIES
 
PAEDIATRICS HIV
PAEDIATRICS HIVPAEDIATRICS HIV
PAEDIATRICS HIV
 
BENIGN LESIONS OF UTERUS
BENIGN LESIONS OF UTERUSBENIGN LESIONS OF UTERUS
BENIGN LESIONS OF UTERUS
 
MEDICAL CERTIFICATE
MEDICAL CERTIFICATEMEDICAL CERTIFICATE
MEDICAL CERTIFICATE
 
Dyslipidaemia
DyslipidaemiaDyslipidaemia
Dyslipidaemia
 
CHILD HEALTH
CHILD HEALTHCHILD HEALTH
CHILD HEALTH
 
URBANIZATION IN MALAYSIA
URBANIZATION IN MALAYSIAURBANIZATION IN MALAYSIA
URBANIZATION IN MALAYSIA
 
PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
PREVENTION & CONTROL OF OCCUPATIONAL DISEASES (Engineering measures)
 
NEURO-OPHTHALMOLOGY
NEURO-OPHTHALMOLOGY NEURO-OPHTHALMOLOGY
NEURO-OPHTHALMOLOGY
 
NASAL POLYPS
NASAL POLYPSNASAL POLYPS
NASAL POLYPS
 
NASAL BONE FRACTURE
NASAL BONE FRACTURENASAL BONE FRACTURE
NASAL BONE FRACTURE
 
FINGERPRINTS AND ADVANCES
FINGERPRINTS AND ADVANCESFINGERPRINTS AND ADVANCES
FINGERPRINTS AND ADVANCES
 
DNA TYPING
DNA TYPINGDNA TYPING
DNA TYPING
 
PRINCIPLE OF ULTRAOUND
PRINCIPLE OF ULTRAOUNDPRINCIPLE OF ULTRAOUND
PRINCIPLE OF ULTRAOUND
 
COMPLICATIONS OF SPINAL & EPIDURAL ANAESTHESIA
COMPLICATIONS OF SPINAL & EPIDURAL ANAESTHESIACOMPLICATIONS OF SPINAL & EPIDURAL ANAESTHESIA
COMPLICATIONS OF SPINAL & EPIDURAL ANAESTHESIA
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Recently uploaded (20)

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Granuloma inguinale, lymphogranuloma venereum, gonorrhea

  • 2. Objective  To understand the underlying causes of the diseases  To understand the clinical findings of the diseases  To know and memorize the drug used for the treatment of the diseases
  • 3. Pathology of the Diseases
  • 4. Granuloma Inguinale  Chronic, relapsing granulomatous anogenital infection  Due to: Calymmatobacterium granulomatis  Lesion occur on the skin or mucous membranes of the genitalia or perineal area  Painless infiltrated nodules that soon slough.  A shallow, sharply demarcated ulcer forms, with a beefy-red friable base of granulation tissue.
  • 5.
  • 6. Lymphogranuloma Venereum  LGV is an acute and chronic sexually transmitted disease caused by Chlamydia trachomatis types L1-L3  Disease is acquired during intercourse or through contact with contaminated exudate from active lesions.  After the genital lesions disappears, the infection spreads to lymph channels and lymph nodes of genital and rectal areas.
  • 7.
  • 8. Gonorrhea  Caused by: Neisseria Gonorrrhoeae  Transmitted during sexual activity and has greater incidence in the 15-29-year-old age group.  Characterized by thick discharge from the penis and vagina.  In addition to male reproductive organs & female genital tract, gonorrhea may infect the rectum, throat, eyes, blood, skin & joints.
  • 9.
  • 11. Granuloma Inguinale  Long duration of therapy  The following recommended regimens should be given for 3 weeks or until all lesions have healed: Drug Dose Route Azithromycin 1g once weekly O Ciprofloxacin 700mg twice daily O Doxycycline 100mg twice daily O Erythromycin 500mg 4 times daily O TREATMENT OF
  • 12. Lymphogranuloma Venereum  Patient with a clinical presentation suggestive of LGV should be treated empirically. Drug Dose Route Azithromycin 1g once weekly For 3 weeks O Doxycycline *C/I in pregnancy 100mg twice daily for 21 days O Erythromycin 500mg 4 times daily For 21 days O TREATMENT OF
  • 13. Gonorrhea  The choice of which regimen to use should be based on the national prevalences of antibiotic resistant organisms.  Nationwide, strains of gonococci that are resistant to penicillin, tetracycline, or ciprofloxacin have been increasingly observed.  Hence no longer be considered as 1st line therapy  Treatment of: 1. Uncomplicated Gonorrhea 2. Disseminated gonococcal infection 3. Endocarditis 4. Postgonococcal urethritis and cervicitis 5. Pelvic inflammatory disease TREATMENT OF
  • 14. Gonorrhea  1. Uncomplicated Gonorrhea  Higher dose of IM Ceftriaxone in combination with second drug (Azithromycin or Doxycyline) regardless of concern for possible secondary infection with chlamydia.  For uncomplicated gonococcal infection of the cervix, urethra, and rectum and pharyngeal gonorrhea Ceftriaxone (250mg IM) + Azithromycin (1000mg orally as SD) / Doxycycline (100mg BD for 7 days) TREATMENT OF *In case where an oral cephalosporin is the only option, Cefixime (400mg, O, SD) can be combined with Azithromycin/Doxycycline as above but a “test of cure” is recommended 1 week after treatment
  • 15. Gonorrhea  2. Disseminated gonococcal infection should be treated with: 1st option  Ceftriaxone (1g daily, IV, until 48 hours after improvement begins) Cefixime (400mg daily, O, to complete at least one week of antimicrobial therapy) 2nd option  Oral fluoroquinolone : Ciprofloxacin (500mg, BD) OR Levofloxacin (500mg, OD) Switched to for 7 days TREATMENT OF
  • 16. Gonorrhea  3. Endocarditis should be treated with:  Ceftriaxone ( 2g every 24 hours, IV, for at least 3 weeks)  4. Postgonococcal urethritis and cervicitis are treated with a regimen of erythromycin, doxycycline or azithromycin  5. Pelvic inflammatory disease: 1st option  Cefoxitin (2g parenterally every 6 hours) OR Cefotetan (2g IV every 12 hours)  Doxycycline (100mg every 12 hours) TREATMENT OF
  • 17. Gonorrhea  Pelvic inflammatory disease: 2nd option  Clindamycin (900mg, IV every 8 hours)  Gentamicin ( IV as a 2mg/kg loading dose followed by 1.5 mg/kg every 8 hours) 3rd option  Ceftriaxone (250mg IM, SD) OR [Cefoxitin (2g IM, SD) + Probenecid (1g orally as a SD)]  Doxycycline (100mg BD for 14 days)  With or without Metronidazole (500mg, BD for 14 days) TREATMENT OF
  • 18. Conclusion 1. Granuloma inguinale  Caused by: Calymmatobacterium granulomatis  Treatment: Drug Dose Route Azithromycin 1g once weekly O Ciprofloxacin 700mg twice daily O Doxycycline 100mg twice daily O Erythromycin 500mg 4 times daily O
  • 19. 2. Lymphogranuloma Venereum:  Caused by: Chlamydia trachomatis types L1-L3  Treatment: Drug Dose Route Azithromycin 1g once weekly For 3 weeks O Doxycycline *C/I in pregnancy 100mg twice daily for 21 days O Erythromycin 500mg 4 times daily For 21 days O
  • 20. 3. Gonorrhea  Caused by: Neisseria Gonorrrhoeae  Treatment: 1.Uncomplicated Gonorrhea -Ceftriaxone/Cefixime+Azithromycin/Doxycycline 2.Disseminated gonococcal infection -CeftriaxoneCefixime or -Oral fluoroquinolones (Ciprofloxacin/Levofloxacin) 3.Endocarditis -Ceftriaxone 4.Postgonococcal urethritis and cervicitis -Erythromycin, Doxycycline or Azithromycin 5.Pelvic inflammatory disease -Cefoxitin/Cefotetan+Doxycycline -Clindamycin+Gentamicin - Ceftriaxone OR [Cefoxitin + Probenecid] + Doxycycline With or without Metronidazole
  • 21. Reference  Stephen J.McPhee, Macine A.Papakadis, Current Medical Diagnosis and Treatment, McGrawHill.